New Silkroutes Group Ltd
SGX:BMT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (6.8), the stock would be worth S$-0.09 (133% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -20.6 | S$0.26 |
0%
|
| Industry Average | 6.8 | S$-0.09 |
-133%
|
| Country Average | 15.6 | S$-0.2 |
-176%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| SG |
|
New Silkroutes Group Ltd
SGX:BMT
|
15.9m SGD | -20.6 | 12.1 | |
| JP |
|
Fuji Oil Co Ltd
F:ACK
|
77.2T EUR | 107 879 562.5 | -1 805 607.9 | |
| IN |
|
Reliance Industries Ltd
NSE:RELIANCE
|
19.4T INR | 102.4 | 23.5 | |
| US |
|
Valero Energy Corp
NYSE:VLO
|
75.5B USD | 16.3 | 31.5 | |
| US |
|
Marathon Petroleum Corp
NYSE:MPC
|
73.2B USD | 8.6 | 17.9 | |
| US |
|
Phillips 66
NYSE:PSX
|
71.9B USD | 46 | 16.1 | |
| PL |
O
|
Orlen SA
PSE:PKN
|
886.7B CZK | 6.9 | 13.7 | |
| PL |
|
Polski Koncern Naftowy Orlen SA
WSE:PKN
|
154.3B PLN | 7 | 13.9 | |
| FI |
|
Neste Oyj
OMXH:NESTE
|
22.6B EUR | 43 | 156.7 | |
| JP |
|
ENEOS Holdings Inc
TSE:5020
|
3.6T JPY | -64.8 | 19.3 | |
| IN |
|
Indian Oil Corporation Ltd
NSE:IOC
|
2T INR | 28.5 | 5.5 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 10 |
| Median | 15.6 |
| 70th Percentile | 28.3 |
| Max | 572 |
Other Multiples
New Silkroutes Group Ltd
Glance View
New Silkroutes Group Ltd. operates as an investment holding company, which engages in healthcare sector. The firm operates in the healthcare sector. The Company’s healthcare division focused on the provision of healthcare and related services, and operates through its subsidiary, Healthsciences International Pte. Ltd. (HSI). HSI owns and operates primary care medical and dental clinics in Singapore. The firm has also extended its healthcare portfolio into healthcare-related supplies through its subsidiary, Shanghai Fengwei Garment Accessory Co., Ltd (Shanghai Fengwei) in China. Shanghai Fengwei produces the non-woven material, which is used to manufacture disposable medical consumables, such as hospital gowns and linen, personal protective equipment and masks. The company owns approximately 16 clinics comprising one dental specialist clinic, eight dental clinics, five family medicine clinics, one aesthetic clinic and one traditional Chinese medicine (TCM) clinic, as well as one dental supplies company.
